Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

NCNA

NuCana (NCNA)

NuCana PLC
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:NCNA
日付受信時刻ニュースソース見出しコード企業名
2024/05/2121 : 00GlobeNewswire Inc.NuCana to Present at TD Cowen’s 5th Annual Oncology Innovation SummitNASDAQ:NCNANuCana PLC
2024/05/1705 : 11Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:NCNANuCana PLC
2024/05/1705 : 01GlobeNewswire Inc.NuCana Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:NCNANuCana PLC
2024/05/1405 : 13Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:NCNANuCana PLC
2024/05/0205 : 01GlobeNewswire Inc.NuCana Regains Compliance with Nasdaq Minimum Bid Price RequirementNASDAQ:NCNANuCana PLC
2024/04/1621 : 00GlobeNewswire Inc.NuCana Announces Completion of ADS Ratio ChangeNASDAQ:NCNANuCana PLC
2024/04/1005 : 30GlobeNewswire Inc.NuCana Presents Data at the AACR 2024 Annual Meeting Highlighting the Ability of NUC-7738 to Profoundly Alter Tumor Biology in a Paired Biopsy Clinical StudyNASDAQ:NCNANuCana PLC
2024/03/2805 : 30GlobeNewswire Inc.NuCana Announces Plan to Implement ADS Ratio ChangeNASDAQ:NCNANuCana PLC
2024/03/2105 : 01GlobeNewswire Inc.NuCana Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Business UpdateNASDAQ:NCNANuCana PLC
2024/02/2722 : 00GlobeNewswire Inc.NuCana to Present at TD Cowen’s 44th Annual Health Care ConferenceNASDAQ:NCNANuCana PLC
2024/02/0622 : 00GlobeNewswire Inc.NuCana to Present at the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:NCNANuCana PLC
2023/11/1706 : 08Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:NCNANuCana PLC
2023/11/1706 : 01GlobeNewswire Inc.NuCana Reports Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:NCNANuCana PLC
2023/11/1406 : 22Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:NCNANuCana PLC
2023/11/1106 : 01GlobeNewswire Inc.NuCana Announces Listing Transfer to Nasdaq Capital MarketNASDAQ:NCNANuCana PLC
2023/11/0906 : 01GlobeNewswire Inc.NuCana to Present at the Jefferies London Healthcare ConferenceNASDAQ:NCNANuCana PLC
2023/11/0205 : 01GlobeNewswire Inc.NuCana to Participate in the Truist Securities 2023 BioPharma SymposiumNASDAQ:NCNANuCana PLC
2023/10/1620 : 10Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:NCNANuCana PLC
2023/10/1620 : 00GlobeNewswire Inc.NuCana Presents Promising Data on NUC-7738 at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023NASDAQ:NCNANuCana PLC
2023/10/1405 : 09Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:NCNANuCana PLC
2023/10/1401 : 30GlobeNewswire Inc.NuCana Presents Encouraging Data on NUC-3373 in Colorectal Cancer at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023NASDAQ:NCNANuCana PLC
2023/09/1821 : 10Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:NCNANuCana PLC
2023/09/1821 : 00GlobeNewswire Inc.NuCana Announces Presentations at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023NASDAQ:NCNANuCana PLC
2023/08/1705 : 08Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:NCNANuCana PLC
2023/08/1705 : 01GlobeNewswire Inc.NuCana Reports Second Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:NCNANuCana PLC
2023/06/1621 : 01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:NCNANuCana PLC
2023/06/0121 : 00GlobeNewswire Inc.NuCana to Present at the Jefferies Healthcare ConferenceNASDAQ:NCNANuCana PLC
2023/05/1805 : 08Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:NCNANuCana PLC
2023/05/1805 : 01GlobeNewswire Inc.NuCana Reports First Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:NCNANuCana PLC
2023/05/1305 : 16Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:NCNANuCana PLC
 Showing the most relevant articles for your search:NASDAQ:NCNA

最近閲覧した銘柄

Delayed Upgrade Clock